EIS impedance of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide. by Nacer Badi (14046883)

Subjects:

DC conductivity of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide. by Nacer Badi (14046883)

Subjects:

XRD pattern of (a) Gadolinium-doped ceria and (b) Lanthanum strontium cobalt oxide. by Nacer Badi (14046883)

Subjects:

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Hypoxia and Cobalt decrease AQP5 mRNA by down-regulating AQP5 transcription. by Jitesh D. Kawedia (384551)

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

“…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”

Irbesartan Decreases ¹⁴C-FDG and ^99mTc-annexin A5 Accumulation Levels. by Yan Zhao (58882)

Subjects:

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Conditional mu-cKO mice show decreased opiate-induced analgesia in the CFA-induced inflammatory pain model. by Raphaël Weibel (458030)

“…Mu-cKO mice displayed a decreased analgesic response in the mechanical sensitivity test for the 0.03 mg/kg fentanyl dose. n=5-10/genotype. …”

Spinal cord of CCI-mice treated with EGCG and compound 30 at 14 dpi showed decreased levels of inflammatory cytokines by Xavier Xifró (719821)

Increased BBB disruption, with a decrease in endothelial ZO-1, claudin-5 and occludin, avoided by GM6001. by Saran Feng (345936)

Induction of hepatic steatosis while improving liver insulin sensitivity and decreasing liver inflammatory response in LFD-fed mice. by Xin Guo (123593)

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

“…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). …”

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial by Bancha Satirapoj (726102)

“…One group consisted of 37 patients treated with standard dose pioglitazone (15 mg/day) and another group consisted of 38 patients treated with low dose pioglitazone (7.5 mg/day). …”

Toward Sustainable Li–S Battery Using Scalable Cathode and Safe Glyme-Based Electrolyte by Vittorio Marangon (9706225)

Subjects:

Toward Sustainable Li–S Battery Using Scalable Cathode and Safe Glyme-Based Electrolyte by Vittorio Marangon (9706225)

Subjects:

Toward Sustainable Li–S Battery Using Scalable Cathode and Safe Glyme-Based Electrolyte by Vittorio Marangon (9706225)

Subjects:

Toward Sustainable Li–S Battery Using Scalable Cathode and Safe Glyme-Based Electrolyte by Vittorio Marangon (9706225)

Subjects:

Table_1_Effectiveness of Improved Use of Chewing Gum During Capsule Endoscopy in Decreasing Gastric Transit Time: A Prospective Randomized Controlled Study.XLS by Liang Huang (114017)

“…<p>Background/Aim: Chewing gum throughout small bowel capsule endoscopy (SBCE) increases completion rates (CRs) but decreases small bowel transit time (SBTT) and diagnostic yield (DY). …”